Published: March 8th 2025 | Updated: March 12th 2025
Ruxolitinib Cream 1.5% Demonstrates Efficacy in Prurigo Nodularis: Phase 3 Findings
Published: March 8th 2025 | Updated: March 12th 2025
Rocatinlimab Shows Significant Efficacy in Moderate to Severe Atopic Dermatitis: Phase 3 IGNITE Trial Results
Published: March 8th 2025 | Updated: March 12th 2025
Icotrokinra Shows Promise for Moderate-to-Severe Plaque Psoriasis in Phase 3 Trials
Published: March 8th 2025 | Updated: March 12th 2025
Tapinarof Cream 1% Demonstrates Sustained Disease Control in Adults, Children with Atopic Dermatitis
Published: March 8th 2025 | Updated: March 12th 2025
Lebrikizumab Improves Patient-Reported Outcomes in Atopic Dermatitis for Patients Previously Treated with Dupilumab
Published: March 7th 2025 | Updated: March 12th 2025
Ruxolitinib Cream Demonstrates Long-Term Disease Control in Atopic Dermatitis